Hereditary peculiarities in individual responses to environmental chem
icals are a common occurrence in human populations. Genetic variation
in glutathione S-transferase, CYP1A2, N-acetyltransferase, and paraoxo
nase exemplify the relationship of metabolic variation to individual s
usceptibility cancer and other toxicants of environmental origin. Heri
table receptor protein variants, a subset of proteins of enormous phar
macogenetic potential that have not thus for been extensively explored
from the pharmacogenetic standpoint, are also considered. Examples of
interest that ore considered include receptor variants associated wit
h retinoic acid resistance in acute promyelocytic leukemia, with parad
oxical responses to antiandrogens in prostrate cancer, and with retini
tis pigmentosa. Additional heritable protein variants of pharmacogenet
ic interest that result in antibiotic-induced deafness, glucocorticoid
-remediable aldosteronism and hypertension, the long-QT syndrome, and
beryllium-induced lung disease are also discussed. These traits demons
trate how knowledge of the molecular basis and mechanism of the varian
t response may contribute to its prevention in sensitive persons as we
ll as to improved therapy for genetically conditioned disorders that a
rise from environmental chemicals. (C) 1995 Wiley-Liss, Inc.